Germany and the WHO infecting the World with herpes using COVID-19 mRNA vaccines

During the first herpes outbreak (called primary herpes), an infected person may experience flu-like symptoms. These include body aches, fever and headache. People who have been vaccinated with Germany’s Pfizer-BioNTech COVID-19 mRNA vaccines are experiencing the same flu-like symptoms as herpes because the human herpes virus protein ORF10 is encoded in SARS-CoV-2 and in mRNA vaccines.

There is more evidence that supports the assertion that mRNA vaccines are infecting the World population with herpes. On August 12, 2021 Europe’s drug regulator EMA published new updates on the safety of mRNA vaccines after it investigated a possible link between mRNA vaccines and a skin reaction called erythema multiforme. Erythema multiforme is a hypersensitivity reaction usually triggered by infections, most commonly herpes simplex virus (HSV).

The human herpes virus ORF10 protein (HHV-8) is the only protein that is present exclusively in SARS-CoV-2 (and not in SARS-CoV or any other human coronaviruses).

The WHO’s COVID-19 Global literature on coronavirus disease suggested the severity of COVID-19 is enhanced by the human herpes virus protein ORF10.

“Could the severity of COVID-19 be enhanced by ORF10 accessory proteins?”

uniqueness of ORF10 and predicted intrinsic characteristics support possible involvement of ORF10 protein in giving COVID-19 its specific characteristics like spread and virulence

World Heath Organization

Since 1972 the WHO/UN has called for/recommended virologists develop the means to prolong virus/coronavirus infections:

An attempt should be made to see if viruses can in fact exert selective effects on immune function. e.g. by depressing (to diminish the activity, strength, or yield of) 7S (IgG) versus 19S (IgM) antibody, or by affecting T cell function as opposed to B cell function. The possibility should be looked into that the immune response to the virus itself may be impaired if the infecting virus damages, more or less selectively the cells responding to the viral antigens. If this proves to be the case, virus-induced immunodepression might conceivably be highly instrumental in prolonging certain virus infections, such as murine leukemia, hepatitis, …

Bulletin of the World Health Organization, Volume 47, p.259, 1972, Recommendations (3)

Virologists did that by genetically engineering/modifying the SARS coronavirus. The human herpes virus protein ORF10 was encoded into the SARS coronavirus to make SARS-CoV-2.

There is currently no cure or preventive treatment for the herpes infection. If a person gets either form of herpes virus infection, they will have it for life , whether or not they experience symptoms.

2003 patent informs us when the herpes virus protein ORF10 was added to the SARS virus by virologists to create SARS-CoV-2. The 2003 Patent US-2006257852-A1 assigned to CHIRON CORP (US), which was acquired by Novartis (Switzerland) on April 20, 2006 specifically names the ORF10 protein – a protein that is exclusively found in SARS-CoV-2 genome and not in SARS-CoV, being used/encoded in the fusion protein of the patented novel SARS coronavirus.